FDA Approves Novolog Mix 50/50
FDA Approves Novolog Mix 50/50
The FDA has approved Novo Nordisk's Novolog Mix 50/50 (50% insulin aspart protamine suspension and 50% insulin aspart injection, [rDNA origin]). Novolog Mix 50/50 is indicated as an adjunct to diet and exercise to improve glycemic control in patients with diabetes mellitus.Posted: August 2008
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
